Single-nucleotide polymorphisms in the PLA2R1 gene are associated with systemic lupus erythematosus and lupus nephritis in a Chinese Han population

Immunologic Research

Volumn 64, Issue 1, 2016, Pages 324-328

  Li, Yuan ^a   Zhou, Aihong ^a,b   Lv, Guanting ^c   Li, Ping ^a   Chen, Si ^a,d   Li, Jing ^a   Wen, Xiaoting ^a   Wu, Ziyan ^a   Zhang, Shulan ^a   Wang, Jibo ^b   Zhang, Fengchun ^a   Li, Yongzhe ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b QINGDAO UNIVERSITY   (China)

^c Beijing DNALead CoLTD   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

LN; PLA2R1; Risk; SLE; SNPs

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; LA ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; PHOSPHOLIPASE A2 RECEPTOR; PLA2R1 PROTEIN, HUMAN;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HAPLOTYPE; HUMAN; IMMUNOGENETICS; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PLA2R1 GENE; POPULATION DISTRIBUTION; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; UNIVERSITY HOSPITAL; CHINA; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS;

ADULT; CASE-CONTROL STUDIES; CHINA; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PHOSPHOLIPASE A2;

EID: 84955707015     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-015-8755-9     Document Type: Article

References (20)

1. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56(7):481–90.
2. Sestak AL, Shaver TS, Moser KL, Neas BR, Harley JB. Familial aggregation of lupus and autoimmunity in an unusual multiplex pedigree. J Rheumatol. 1999;26(7):1495–9.
3. Reichlin M, Harley JB, Lockshin MD. Serologic studies of monozygotic twins with systemic lupus erythematosus. Arthritis Rheum. 1992;35(4):457–64.
4. Sestak AL, Nath SK, Sawalha AH, Harley JB. Current status of lupus genetics. Arthritis Res Ther. 2007;9(3):210.
5. Contreras G, Pardo V, Cely C, Borja E, Hurtado A, De La Cuesta C, et al. Factors associated with poor outcomes in patients with lupus nephritis. Lupus. 2005;14(11):890–5.
6. Mosaad YM, Hammad A, Fawzy Z, El-Refaaey A, Tawhid Z, Hammad EM, et al. C1q rs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis. Clin Exp Immunol. 2015;182(1):23–34.
7. Chu ZT, Tsuchiya N, Kyogoku C, Ohashi J, Qian YP, Xu SB, et al. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens. 2004;63(1):21–7.
8. Sanchez E, Nadig A, Richardson BC, Freedman BI, Kaufman KM, Kelly JA, et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis. 2011;70(10):1752–7.
9. Bollain-Y-Goytia JJ, Arellano-Rodriguez M, Torres-Del-Muro FJ, Daza-Benitez L, Munoz-Valle JF, Avalos-Diaz E, et al. Soluble fas and the -670 polymorphism of fas in lupus nephritis. Int J Nephrol. 2014;2014:780406.
10. Zhou XJ, Nath SK, Qi YY, Cheng FJ, Yang HZ, Zhang Y, et al. Brief Report: identification of MTMR3 as a novel susceptibility gene for lupus nephritis in northern Han Chinese by shared-gene analysis with IgA nephropathy. Arthritis Rheumatol. 2014;66(10):2842–8.
11. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med. 2011;364(7):616–26.
12. Llorca O. Extended and bent conformations of the mannose receptor family. Cell Mol Life Sci. 2008;65(9):1302–10.
13. Beck LJ, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21.
14. Bernard D, Vindrieux D. PLA2R1: expression and function in cancer. Biochim Biophys Acta. 2014;1846(1):40–4.
15. Menschikowski M, Platzbecker U, Hagelgans A, Vogel M, Thiede C, Schonefeldt C, et al. Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells. BMC Cancer. 2012;12:576.
16. Bullich G, Ballarin J, Oliver A, Ayasreh N, Silva I, Santin S, et al. HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2014;9(2):335–43.
17. Lv J, Hou W, Zhou X, Liu G, Zhou F, Zhao N, et al. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy. J Am Soc Nephrol. 2013;24(8):1323–9.
18. Coenen MJ, Hofstra JM, Debiec H, Stanescu HC, Medlar AJ, Stengel B, et al. Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J Am Soc Nephrol. 2013;24(4):677–83.
19. Kim S, Chin HJ, Na KY, Kim S, Oh J, Chung W, et al. Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy. Nephron Clin Pract. 2011;117(3):c253–8.
20. Segelmark M. Genes that link nephritis to autoantibodies and innate immunity. N Engl J Med. 2011;364(7):679–80.